Shanghai Xuerong Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 928.810 million compared to CNY 995.800 million a year ago. Operating loss was CNY 98.233 million compared to operating Income of CNY 142.471 million a year ago. Net loss was CNY 70.702 million compared to net income of CNY 155.466 million a year ago. Basic loss per share from continuing operations was CNY 0.16 compared to basic earnings per share from continuing operations of CNY 0.36 a year ago.